bluebird bio Inc (NAS:BLUE)
$ 0.9624 0.06 (6.64%) Market Cap: 185.50 Mil Enterprise Value: 303.88 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 25/100

bluebird bio Inc at Leerink Global Healthcare Conference Transcript

Feb 26, 2020 / 07:30PM GMT
Release Date Price: $47.06 (-0.01%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Good afternoon, everyone. I am Mani Foroohar, Managing Director and Senior Analyst here at SVB Leerink, with genetic medicines. And I have the good fortune to be hosting Dave Davidson; and Chip Baird, CMO and CFO, respectively, of our top pick, bluebird bio. Chip, how do you feel? Are you thinking about diving into the slides? Or you want to go straight into questions? How do you want to handle it?

William D. Baird
bluebird bio, Inc. - CFO

Yes. I have a couple of slides, maybe just to introduce bluebird and what's coming up this year and then we can get into the Q&A, how's that sound?

Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Fire away.

William D. Baird
bluebird bio, Inc. - CFO

Awesome. Well, thank you, Mani, and thanks to everyone at SVB Leerink for having us here. We're pleased to be a part of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot